Insulin, Physical Activity, and Caloric Intake in Postmenopausal Women: Breast Cancer Implications
- 15 November 2004
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 22 (22), 4507-4513
- https://doi.org/10.1200/jco.2004.04.119
Abstract
Increased physical activity and programs to reduce body mass index (BMI) with both increased physical activity and decreased caloric intake have been proposed to reduce insulin as a potential mediator of breast cancer and other chronic diseases. However, there are few data on the relative contribution of physical activity, caloric intake, and BMI to fasting insulin levels. An ethnically diverse subsample of 2,996 mostly healthy postmenopausal women with no prior cancer history was randomly identified from the 161,809 participants in the Women's Health Initiative clinical trials and observational study. Information was collected on diet, recreational physical activity, and anthropometrics including BMI. Fasting insulin levels were determined. Using a cross-sectional design, insulin levels were then compared across quintiles of caloric intake and physical activity in linear regression model analyses controlled for BMI and other factors. Lower BMI (P < .0001), higher levels of physical activity (P < .0001), and lower caloric intake (P < .02) were all independently associated with significantly lower mean fasting insulin levels throughout the range of observed values. Insulin levels of 8.74 μU/mL ± 4.16 SD were seen in the highest physical activity and lowest caloric intake quintile compared with insulin levels of 15.08 μU/mL ± 16.32 SD in the lowest physical activity and highest caloric intake quintile (P < .0001). These findings suggest that reduction in BMI achieved by increasing physical activity, reducing caloric intake, or both, should lower insulin levels, providing support for clinical trials evaluating insulin level change and breast cancer risk.Keywords
This publication has 31 references indexed in Scilit:
- Serum High-Density Lipoprotein Cholesterol, Metabolic Profile, and Breast Cancer RiskJNCI Journal of the National Cancer Institute, 2004
- Obesity, adipocytokines, and insulin resistance in breast cancerObesity Reviews, 2004
- Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysisThe Lancet, 2004
- Evaluation of the synergistic effect of insulin resistance and insulin‐like growth factors on the risk of breast carcinomaCancer, 2004
- Serum concentrations of IGF‐I, IGFBP‐3 and c‐peptide and risk of hyperplasia and cancer of the breast in postmenopausal womenInternational Journal of Cancer, 2003
- Nutrition, Insulin, Insulin-like Growth Factors and CancerHormone and Metabolic Research, 2003
- Effects of dietary intervention on IGF-I and IGF-binding proteins, and related alterations in sex steroid metabolism: the Diet and Androgens (DIANA) Randomised TrialEuropean Journal of Clinical Nutrition, 2003
- Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. AdultsNew England Journal of Medicine, 2003
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Body size and breast cancer prognosis: A critical review of the evidenceBreast Cancer Research and Treatment, 1990